#2537 - David Sinclair

David Sinclair holds the Order of Australia and is a Harvard researcher whose book Lifespan has been published in 40 languages. He argues that aging has a single identifiable root cause common to nearly every cell, and that as recently as 2019 it was considered scientifically unacceptable to claim aging could be reversed. A 2020 Nature cover paper demonstrated for the first time that the aging process could be safely reversed in living tissue, which Sinclair compares to reinstalling software in a cell.

The mechanism uses three of the four Yamanaka factors, the genes called OSK, also referred to as ER100 for epigenetic reprogramming 100. The fourth factor, M, is deliberately excluded because full reprogramming would strip cells of their identity entirely and would likely kill a person within minutes. Using only OSK reverses cells approximately 75 to 80 percent back toward youth. The delivery system is a domesticated, non-pathogenic virus-like capsule whose surface spike proteins can be swapped to target specific tissues. The first FDA-approved human trial targets glaucoma, chosen because the eye is an enclosed environment where the capsules cannot spread. The first patient, effectively blind in one eye from glaucoma-related damage, received trillions of the capsules with no adverse events reported. Approximately 40 million people in the US have glaucoma. In mouse models the same approach has cured macular degeneration, reversed fatty liver disease, and regrown muscle and bone in damaged joints. A PhD student named Nalat also found that activating OSK in cancer cells caused human tumors growing in mice to shrink, with the hypothesis that reprogrammed cancer cells recognize their original identity and undergo apoptosis.

Sinclair's lab is also developing a drink and a pill that produce rejuvenation similar to OSK gene therapy. The specific components remain classified. The mechanism centers on TET genes, of which there are three, that produce enzymes removing methyl groups from DNA and controlling the biological clock. Removing TET genes blocks the drink from working, confirming the effect operates through clock resetting rather than general cellular health improvement. Vision recovery using gene therapy takes six to eight weeks, but the drink achieved results in four weeks in mice. Sinclair says reversing brain age in mice improves learning and there are unpublished hints that lost memories return, leading him to argue that Alzheimer's patients may retain memories but cannot access them. He will not personally take the experimental compound because it is not yet legal and a bad outcome would damage the broader research program.

Sinclair's lab is collaborating with a group at St. Jude's Hospital using AI-assisted computational docking of molecules against protein structures solved by Google DeepMind. The screening pool grew from 10 billion to a trillion theoretical and known molecules, and AI completed in two months work Sinclair estimates would have taken approximately 160 years by traditional methods, producing roughly 200 candidate molecules set to begin testing against human cells within weeks of the recording. All federal funding to Harvard Medical School was cut during a dispute with the federal government, and Sinclair's lab now survives on donations with a budget of approximately three million dollars. A foreign government investment of 160 million dollars into one of his companies was blocked by the US government out of concern about super soldier applications of the technology.

Tadalafil and sildenafil show resistance to certain cancers in mice and apparently in humans. Tadalafil suppresses MDSCs that shield tumors from immune attack, causing tumors to shrink. Sildenafil blocks cancer cells from accessing cholesterol, which many cancers depend on for growth. Sinclair also flagged that dutasteride, an oral DHT inhibitor, can cause severe depression and suicidal ideation in some individuals, and emphasized that doctor supervision is necessary for any of these interventions. GLP-1 drugs were found in a Harvard study by researcher Joe Rizzo to be associated with patients being 68.6 times more likely to develop non-arteritic ischemic optic neuropathy, though Sinclair and Rogan both acknowledged correlation does not equal causation and that GLP-1 drugs have probably saved millions of lives. Anyone experiencing sudden vision changes should seek emergency medical evaluation immediately.

Sinclair proposes two biological states: abundance mode, driven by high protein intake and promoting growth, and adversity mode, driven by plant-based eating and exercise and promoting longevity. He follows a mostly plant-based diet based on 30 years of research across a variety of animals, though he acknowledged this is not proven in humans. Rogan disagreed, arguing meat is the most nutrient-dense food available, and also stated that Blue Zones research is largely fraudulent, citing Okinawa as a case where families failed to report deaths to keep deceased individuals on government census rolls. A Harvard study tracking World War II veterans for approximately 40 years found the top predictor of longevity was having a reliable partner you love and enjoy, and that combining good relationships, not smoking, not drinking, adequate rest, and exercise extended life by approximately 15 years. Sinclair argues that loneliness and chronic stress from bad relationships are among the greatest contributors to poor health outcomes, and that epigenetic clocks show measurable accelerated aging during stress and relationship breakups.

Sinclair identifies insufficient blood flow to tissues as a major and underappreciated driver of age-related disease. He points to vascular dementia as the second largest cause of dementia in the world and describes it as the easiest form of dementia to reverse.